Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
251.00    6.00 (2.45%)
Bid:
250.50
Ask:
253.50
Spread: 3.00 (1.198%)
Market Cap: £146.42m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

5 Dec 2019 07:00

RNS Number : 7186V
MJ Gleeson PLC
05 December 2019
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, will today hold its Annual General Meeting in Sheffield. Dermot Gleeson, Chairman, will make the following comments:

"Demand at Gleeson Homes is strong with net reservations since the start of the current financial year to 30 June 2020 ("FY2020") up more than 10% compared with the same period last year.

"Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 13,042 plots with a gross development value of £1.7 billion, of which 6,910 plots are owned and 6,132 are conditionally purchased.

"The division currently has 64 active sites, compared with 62 at this time last year, but expects to open significantly more sites in the second half of FY2020.

"Strong demand, good mortgage availability and our ability to offer attractive levels of affordability to our customers, means the outlook for the division remains very positive.

 

"The Board expects Gleeson Homes to record an increase in completions for the half year to 31 December 2019 of approximately 10% compared with the prior half year total of 691 units; and an increase in completions for FY2020 of at least 10% compared with the prior year total of 1,529 units.

"Gleeson Strategic Land continues to experience strong demand for consented land. The majority of the division's land sales are expected in the second half of FY2020. Accordingly, and in line with our expectations, results for the first half are expected to be lower than the unusually high results for the first half last year.

"The division's land pipeline currently consists of 64 sites which have the potential to deliver approximately 22,175 plots. The portfolio includes 10 sites which now have planning permission.

"Against this background the Board remains confident that the Group's results for FY2020 will be in line with expectations.

"We announced in September the appointment of Andrew Coppel and Fiona Goldsmith to the Board as non-executive Directors with effect from 1st October 2019. Colin Dearlove, Senior Independent Director and Ross Ancell, Non-Executive Director will be stepping down from the Board in June 2020. The Board would like to thank both Colin and Ross for the invaluable guidance and support they have provided over the years."

 

5 December 2019

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612900

James Thomson

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKMMGZVDGGLZM
Date   Source Headline
10th Jun 20197:00 amRNSRe Directorate
31st May 20197:00 amRNSTotal Voting Rights
30th May 20197:00 amRNSHolding(s) in Company
22nd May 20197:00 amRNSNotice of Site Visit
10th May 201910:52 amRNSDirector/PDMR Shareholding
2nd May 20197:00 amRNSSmaller related party land purchase
30th Apr 20197:00 amRNSTotal Voting Rights
29th Apr 201912:25 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSStatement re press speculation
29th Mar 20197:00 amRNSTotal Voting Rights
7th Mar 201911:16 amRNSDirector/PDMR Shareholding
28th Feb 20197:00 amRNSTotal Voting Rights
14th Feb 20197:00 amRNSHalf-year Report
8th Feb 201911:20 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSTotal Voting Rights
8th Jan 20194:51 pmRNSDirector/PDMR Shareholding
7th Jan 20197:00 amRNSNotice of Results and Trading Update
31st Dec 20187:00 amRNSTotal Voting Rights
19th Dec 20184:35 pmRNSPrice Monitoring Extension
11th Dec 20189:16 amRNSDirector/PDMR Shareholding
7th Dec 201810:41 amRNSResult of AGM
6th Dec 20187:00 amRNSAGM Statement
30th Nov 20187:00 amRNSTotal Voting Rights
7th Nov 20189:50 amRNSDirector/PDMR Shareholding
5th Nov 20189:00 amRNSNotice of AGM
31st Oct 20187:00 amRNSTotal Voting Rights
10th Oct 20184:55 pmRNSPerformance Share Plan award to Directors/PDMRs
9th Oct 201812:01 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSTotal Voting Rights
17th Sep 20187:00 amRNSFinal Results
7th Sep 20189:50 amRNSDirector/PDMR Shareholding
31st Aug 20187:00 amRNSTotal Voting Rights
9th Aug 20187:00 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSTotal Voting Rights
9th Jul 20189:05 amRNSDirector/PDMR Shareholding
5th Jul 20187:00 amRNSTrading Update
29th Jun 20187:00 amRNSTotal Voting Rights
6th Jun 20183:14 pmRNSDirector/PDMR Shareholding
31st May 20187:00 amRNSTotal Voting Rights
10th May 20189:57 amRNSDirector/PDMR Shareholding
30th Apr 20187:00 amRNSTotal Voting Rights
13th Apr 201811:32 amRNSDirector/PDMR Shareholding
6th Apr 201811:45 amRNSDirector/PDMR Shareholding
29th Mar 20187:00 amRNSTotal Voting Rights
12th Mar 201810:00 amRNSNotice of Results
6th Mar 20186:22 pmRNSDirector/PDMR Shareholding
1st Mar 20188:57 amRNSHolding(s) in Company
28th Feb 20185:45 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSTotal Voting Rights
20th Feb 201810:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.